Modafinil - PubMed
- ️Mon Feb 06 2023
Book
In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan.
2023 Feb 6.
Affiliations
- PMID: 30285371
- Bookshelf ID: NBK531476
Free Books & Documents
Book
Modafinil
Karl Greenblatt et al.
Free Books & Documents
Excerpt
Modafinil is a non-amphetamine central nervous system stimulant with wakefulness-promoting properties. It is used in the treatment of conditions which cause excessive daytime sleepiness. In the United States, modafinil is Food and Drug Administration-approved for the treatment of the following in adults: narcolepsy, sleep work shift disorder, and obstructive sleep apnea (adjunct to continuous positive airway pressure). It also has several off-label indications. This activity will highlight the mechanism of action, adverse event profile, pharmacology, monitoring, and relevant interactions of modafinil, pertinent for members of the interprofessional team in the treatment of patients with conditions where modafinil has a therapeutic purpose.
Copyright © 2025, StatPearls Publishing LLC.
Conflict of interest statement
Disclosure: Karl Greenblatt declares no relevant financial relationships with ineligible companies.
Disclosure: Ninos Adams declares no relevant financial relationships with ineligible companies.
Sections
Similar articles
-
Drug therapy for obstructive sleep apnoea in adults.
Mason M, Welsh EJ, Smith I. Mason M, et al. Cochrane Database Syst Rev. 2013 May 31;2013(5):CD003002. doi: 10.1002/14651858.CD003002.pub3. Cochrane Database Syst Rev. 2013. PMID: 23728641 Free PMC article. Review.
-
Gadolinium Magnetic Resonance Imaging.
Ibrahim MA, Hazhirkarzar B, Dublin AB. Ibrahim MA, et al. 2023 Jul 3. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan–. 2023 Jul 3. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan–. PMID: 29494094 Free Books & Documents.
-
Wang Y, Zhang W, Ye H, Xiao Y. Wang Y, et al. Sleep Med Rev. 2024 Dec;78:101997. doi: 10.1016/j.smrv.2024.101997. Epub 2024 Aug 30. Sleep Med Rev. 2024. PMID: 39243682 Review.
-
Dittrich RP, De Jesus O. Dittrich RP, et al. 2022 Dec 26. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan–. 2022 Dec 26. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan–. PMID: 33620825 Free Books & Documents.
-
Crossan K, Sheer AJ. Crossan K, et al. 2023 Jan 30. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan–. 2023 Jan 30. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan–. PMID: 35201712 Free Books & Documents.
References
-
- Biederman J, Swanson JM, Wigal SB, Kratochvil CJ, Boellner SW, Earl CQ, Jiang J, Greenhill L. Efficacy and safety of modafinil film-coated tablets in children and adolescents with attention-deficit/hyperactivity disorder: results of a randomized, double-blind, placebo-controlled, flexible-dose study. Pediatrics. 2005 Dec;116(6):e777-84. - PubMed
-
- Goez HR, Scott O, Nevo N, Bennett-Back O, Zelnik N. Using the test of variables of attention to determine the effectiveness of modafinil in children with attention-deficit hyperactivity disorder (ADHD): a prospective methylphenidate-controlled trial. J Child Neurol. 2012 Dec;27(12):1547-52. - PubMed
-
- Arnold VK, Feifel D, Earl CQ, Yang R, Adler LA. A 9-week, randomized, double-blind, placebo-controlled, parallel-group, dose-finding study to evaluate the efficacy and safety of modafinil as treatment for adults with ADHD. J Atten Disord. 2014 Feb;18(2):133-44. - PubMed
-
- Goss AJ, Kaser M, Costafreda SG, Sahakian BJ, Fu CH. Modafinil augmentation therapy in unipolar and bipolar depression: a systematic review and meta-analysis of randomized controlled trials. J Clin Psychiatry. 2013 Nov;74(11):1101-7. - PubMed